With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

Twelve GLP-1 RA medications were studied ... and the effectiveness outcome were all types of composite fractures. The researchers estimated that that the risk for fractures was 45% lower and ...

Some of these prescriptions were originally designed to lower blood sugar levels in people with type ... GLP-1 agonist these days, but individuals who are considering using one of these ...

The findings highlight how the integration of glucagon-like peptide-1 (GLP-1) medications for weight loss is reshaping the Aesthetics market, fueling significant growth for practices across the ...

The recent surge in use of GLP-1 drugs led Dr. Spector and first author Dr. Seth Aschen, then a plastic surgery resident at NewYork-Presbyterian/Weill Cornell Medical Center, to see if patients ...

FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as ...

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after ...